We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
+$77M
Cap. Flow %
2.17%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128

Top Buys

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$138M
2
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$131M
3
EDR
Endeavor Group Holdings, Inc.
EDR
+$127M
4
MRO
Marathon Oil Corporation
MRO
+$123M
5
CHX
ChampionX
CHX
+$98.3M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$638M
2
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$51.2M
3
DFS
Discover Financial Services
DFS
+$45.1M
4
SCRM
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$18.4M
5
NSC icon
Norfolk Southern
NSC
+$17.7M

Sector Composition

Rank Sector Weight
1 Energy 26.53%
2 Technology 21.03%
3 Healthcare 14.68%
4 Industrials 8.19%
5 Materials 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LTC
326
LTC Properties
LTC
$2.13B
$719K 0.02%
20,854
-4,071
-16% -$136K
UTHR icon
327
United Therapeutics
UTHR
$22.9B
$718K 0.02%
2,254
+726
+48% +$192K
ALLK
328
DELISTED
Allakos
ALLK
$717K 0.02%
716,565
+74,900
+12% +$89K
SPKL
329
Spark I Acquisition Corp
SPKL
$101M
$714K 0.02%
68,991
– –
MLYS icon
330
Mineralys Therapeutics
MLYS
$2.38B
$701K 0.02%
59,931
+1,457
+2% +$18.4K
MHO icon
331
M/I Homes
MHO
$3.71B
$696K 0.02%
+5,700
New +$697K
GILD icon
332
Gilead Sciences
GILD
$162B
$686K 0.02%
+10,000
New +$667K
AURA icon
333
Aura Biosciences
AURA
$799M
$685K 0.02%
90,619
+23,294
+35% +$171K
HLVX
334
DELISTED
HilleVax
HLVX
$679K 0.02%
46,970
+1,294
+3% +$17.8K
INSM icon
335
CALL
Insmed
INSM
$28.9B
$677K 0.02%
+60,000
New +$2.33M
XFOR icon
336
X4 Pharmaceuticals
XFOR
$393M
$673K 0.02%
38,684
-5,833
-13% -$191K
MU icon
337
Micron Technology
MU
$996B
$658K 0.02%
5,000
-20,000
-80% -$2.52M
THRD
338
DELISTED
Third Harmonic Bio
THRD
$640K 0.02%
49,251
+848
+2% +$10.5K
ARDX icon
339
Ardelyx
ARDX
$1.2B
$627K 0.02%
84,593
-27,296
-24% -$192K
INSP icon
340
Inspire Medical Systems
INSP
$1.7B
$614K 0.02%
4,585
-3,500
-43% -$662K
SLNO
341
DELISTED
Soleno Therapeutics
SLNO
$612K 0.02%
+15,000
New +$636K
ACRV icon
342
Acrivon Therapeutics
ACRV
$72.3M
$610K 0.02%
105,249
-21,700
-17% -$175K
IRON icon
343
Disc Medicine
IRON
$2.97B
$600K 0.02%
13,319
+10,000
+301% +$340K
CNTX icon
344
Context Therapeutics
CNTX
$46.3M
$589K 0.02%
293,758
-2,917
-1% -$5.03K
PYPL icon
345
PayPal
PYPL
$51.1B
$580K 0.02%
10,000
-7,500
-43% -$477K
BHAC
346
DELISTED
Focus Impact BH3 Acquisition Company Class A Common Stock
BHAC
$577K 0.02%
54,209
– –
SKIL icon
347
Skillsoft
SKIL
$72.1M
$577K 0.02%
41,692
– –
BSX icon
348
Boston Scientific
BSX
$71.4B
$547K 0.02%
7,100
-7,700
-52% -$564K
SABR icon
349
PUT
Sabre
SABR
$886M
$544K 0.02%
+688,600
New +$1.93M
COTY icon
350
PUT
Coty
COTY
$2.39B
$542K 0.02%
1,264,500
-100,000
-7% -$1.07M
12 13
14
15 16

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.